Form 4 for PBH Prestige Consumer Healthcare Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001104659-24-025498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-20 | 2024-02-15 | PBH | Mekhail Adel | EVP, Marketing, Sales | M - OptEx | $37.46 | +15.5K | 30.2K | +106% | +$582.5K |
| DM | 2024-02-20 | 2024-02-15 | PBH | Mekhail Adel | EVP, Marketing, Sales | S - Sale+OE | $69.11 | -15.5K | 18.7K | -45% | -$1.07M |
| DM | 2024-02-20 | 2024-02-15 | PBH | Mekhail Adel | EVP, Marketing, Sales | M - OptEx | $0.00 | -15.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-02-15 | M | A | 4,000 | $30.19 | 22,681 | D | — | — | |
| 2 | Common | Common Stock, par value $0.01 per share | 2024-02-15 | S | D | 4,000 | $69.21 | 18,681 | D | — | — | (F1) Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $68.79 to $69.21. |
| 3 | Common | Common Stock, par value $0.01 per share | 2024-02-15 | M | A | 11,549 | $39.98 | 30,230 | D | — | — | |
| 4 | Common | Common Stock, par value $0.01 per share | 2024-02-15 | S | D | 11,549 | $69.08 | 18,681 | D | — | — | (F2) Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $68.91 to $69.08. |
| 5 | Derivative | Employee Stock Options (rights to buy) | 2024-02-15 | M | D | 11,549 | $0.00 | 0 | D | $39.98 · — to 2030-05-04 | 11,549 Common Stock | (F4) The options vested in three installments each of 3,850 shares on May 4, 2021 and May 4, 2022 and 3,849 shares on May 4, 2023. |
| 6 | Derivative | Employee Stock Options (rights to buy) | 2024-02-15 | M | D | 4,000 | $0.00 | 0 | D | $30.19 · — to 2029-05-13 | 4,000 Common Stock | (F3) The options vested and became exercise on the third anniversary of the grant date. |